VANGUARD Blood cardioplegia Systems (3 models)— 510(k) K250150

Substantially Equivalent

Sorin Group Italia S.R.L.

FDA 510(k) clearance K250150 for VANGUARD Blood cardioplegia Systems (3 models), Substantially Equivalent on 2025-05-30. Applicant: Sorin Group Italia S.R.L.. Device class: 2.

Clearance details

Device name as filed
VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set with shunt); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood Cardioplegia Set Mini)
Applicant
Sorin Group Italia S.R.L.
Product code
Code DTR
Device class
Class 2
Regulation
21 CFR 870.4240
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Mirandola (Modena), IT
Download summary PDFView on FDA.gov ↗

Recent devices under product code DTR

view all

More clearances from Sorin Group Italia S.R.L.

view all

Adverse events under product code DTR

product code DTR
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.